Cargando…

Selectivity of Terpyridine Platinum Anticancer Drugs for G-quadruplex DNA

Guanine-rich DNA can form four-stranded structures called G-quadruplexes (G4s) that can regulate many biological processes. Metal complexes have shown high affinity and selectivity toward the quadruplex structure. Here, we report the comparison of a panel of platinum (II) complexes for quadruplex DN...

Descripción completa

Detalles Bibliográficos
Autores principales: Morel, Elodie, Beauvineau, Claire, Naud-Martin, Delphine, Landras-Guetta, Corinne, Verga, Daniela, Ghosh, Deepanjan, Achelle, Sylvain, Mahuteau-Betzer, Florence, Bombard, Sophie, Teulade-Fichou, Marie-Paule
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6385020/
https://www.ncbi.nlm.nih.gov/pubmed/30678027
http://dx.doi.org/10.3390/molecules24030404
_version_ 1783397112656953344
author Morel, Elodie
Beauvineau, Claire
Naud-Martin, Delphine
Landras-Guetta, Corinne
Verga, Daniela
Ghosh, Deepanjan
Achelle, Sylvain
Mahuteau-Betzer, Florence
Bombard, Sophie
Teulade-Fichou, Marie-Paule
author_facet Morel, Elodie
Beauvineau, Claire
Naud-Martin, Delphine
Landras-Guetta, Corinne
Verga, Daniela
Ghosh, Deepanjan
Achelle, Sylvain
Mahuteau-Betzer, Florence
Bombard, Sophie
Teulade-Fichou, Marie-Paule
author_sort Morel, Elodie
collection PubMed
description Guanine-rich DNA can form four-stranded structures called G-quadruplexes (G4s) that can regulate many biological processes. Metal complexes have shown high affinity and selectivity toward the quadruplex structure. Here, we report the comparison of a panel of platinum (II) complexes for quadruplex DNA selective recognition by exploring the aromatic core around terpyridine derivatives. Their affinity and selectivity towards G4 structures of various topologies have been evaluated by FRET-melting (Fluorescence Resonance Energy Transfert-melting) and Fluorescent Intercalator Displacement (FID) assays, the latter performed by using three different fluorescent probes (Thiazole Orange (TO), TO-PRO-3, and PhenDV). Their ability to bind covalently to the c-myc G4 structure in vitro and their cytotoxicity potential in two ovarian cancerous cell lines were established. Our results show that the aromatic surface of the metallic ligands governs, in vitro, their affinity, their selectivity for the G4 over the duplex structures, and platination efficiency. However, the structural modifications do not allow significant discrimination among the different G4 topologies. Moreover, all compounds were tested on ovarian cancer cell lines and normal cell lines and were all able to overcome cisplatin resistance highlighting their interest as new anticancer drugs.
format Online
Article
Text
id pubmed-6385020
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-63850202019-02-23 Selectivity of Terpyridine Platinum Anticancer Drugs for G-quadruplex DNA Morel, Elodie Beauvineau, Claire Naud-Martin, Delphine Landras-Guetta, Corinne Verga, Daniela Ghosh, Deepanjan Achelle, Sylvain Mahuteau-Betzer, Florence Bombard, Sophie Teulade-Fichou, Marie-Paule Molecules Article Guanine-rich DNA can form four-stranded structures called G-quadruplexes (G4s) that can regulate many biological processes. Metal complexes have shown high affinity and selectivity toward the quadruplex structure. Here, we report the comparison of a panel of platinum (II) complexes for quadruplex DNA selective recognition by exploring the aromatic core around terpyridine derivatives. Their affinity and selectivity towards G4 structures of various topologies have been evaluated by FRET-melting (Fluorescence Resonance Energy Transfert-melting) and Fluorescent Intercalator Displacement (FID) assays, the latter performed by using three different fluorescent probes (Thiazole Orange (TO), TO-PRO-3, and PhenDV). Their ability to bind covalently to the c-myc G4 structure in vitro and their cytotoxicity potential in two ovarian cancerous cell lines were established. Our results show that the aromatic surface of the metallic ligands governs, in vitro, their affinity, their selectivity for the G4 over the duplex structures, and platination efficiency. However, the structural modifications do not allow significant discrimination among the different G4 topologies. Moreover, all compounds were tested on ovarian cancer cell lines and normal cell lines and were all able to overcome cisplatin resistance highlighting their interest as new anticancer drugs. MDPI 2019-01-23 /pmc/articles/PMC6385020/ /pubmed/30678027 http://dx.doi.org/10.3390/molecules24030404 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Morel, Elodie
Beauvineau, Claire
Naud-Martin, Delphine
Landras-Guetta, Corinne
Verga, Daniela
Ghosh, Deepanjan
Achelle, Sylvain
Mahuteau-Betzer, Florence
Bombard, Sophie
Teulade-Fichou, Marie-Paule
Selectivity of Terpyridine Platinum Anticancer Drugs for G-quadruplex DNA
title Selectivity of Terpyridine Platinum Anticancer Drugs for G-quadruplex DNA
title_full Selectivity of Terpyridine Platinum Anticancer Drugs for G-quadruplex DNA
title_fullStr Selectivity of Terpyridine Platinum Anticancer Drugs for G-quadruplex DNA
title_full_unstemmed Selectivity of Terpyridine Platinum Anticancer Drugs for G-quadruplex DNA
title_short Selectivity of Terpyridine Platinum Anticancer Drugs for G-quadruplex DNA
title_sort selectivity of terpyridine platinum anticancer drugs for g-quadruplex dna
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6385020/
https://www.ncbi.nlm.nih.gov/pubmed/30678027
http://dx.doi.org/10.3390/molecules24030404
work_keys_str_mv AT morelelodie selectivityofterpyridineplatinumanticancerdrugsforgquadruplexdna
AT beauvineauclaire selectivityofterpyridineplatinumanticancerdrugsforgquadruplexdna
AT naudmartindelphine selectivityofterpyridineplatinumanticancerdrugsforgquadruplexdna
AT landrasguettacorinne selectivityofterpyridineplatinumanticancerdrugsforgquadruplexdna
AT vergadaniela selectivityofterpyridineplatinumanticancerdrugsforgquadruplexdna
AT ghoshdeepanjan selectivityofterpyridineplatinumanticancerdrugsforgquadruplexdna
AT achellesylvain selectivityofterpyridineplatinumanticancerdrugsforgquadruplexdna
AT mahuteaubetzerflorence selectivityofterpyridineplatinumanticancerdrugsforgquadruplexdna
AT bombardsophie selectivityofterpyridineplatinumanticancerdrugsforgquadruplexdna
AT teuladefichoumariepaule selectivityofterpyridineplatinumanticancerdrugsforgquadruplexdna